期刊文献+

仙台病毒颗粒数实时荧光定量PCR检测方法的建立及验证 被引量:1

Development and application of real-time qPCR assay for detecting Sendai virus gene copy number
原文传递
导出
摘要 目的 建立并验证仙台病毒颗粒数的real-time qPCR检测方法。方法 提取仙台病毒核酸和扩增仙台病毒N基因并构建重组质粒作为参考品,建立TaqMan探针法real-time qPCR方法,并进行线性、重复性、灵敏度和精密度验证。结果 该方法可以检测到仙台病毒的基因组拷贝数,在1.024 × 103~5 × 1010拷贝数/μl范围内,线性良好,R2>99%;检测样品的加标回收率为84.56% ~119.48%。结论 与传统的检测颗粒数血凝试验相比,此方法的灵敏度更高,重复性更好,定量准确,可用于以仙台病毒为载体的疫苗颗粒数的检测,进而检测疫苗产品的比滴度。 Objective To develop a real-time quantitative PCR(qPCR)assay for detecting Sendai virus gene copy number.Methods The recombinant plasmid was constructed and a reference used to establish the real-time qPCR method with the TaqMan probe and verified for reproducibility and sensitivity.Results The linear range of the developed real-time qPCR assay was 1.024×103~5×1010 copies/μl,with an R2 value of more than 0.99.The standard recovery of the tested samples was 84.56%~119.48%.Conclusions Compared with traditional hernagglutination assay for particle number detection,this method has higher sensitivity,better repeatability and high quantitative accuracy.It can be used for the detection of particle number of vaccine with sendai virus as the carrier,so as to detect the specific activity of vaccine products.
作者 张晓焕 苏文浩 任秀秀 赵婷婷 王轶男 卫江波 Zhang Xiaohuan;Su Wenhao;Ren Xiuxiu;Zhao Tingting;Wang Yinan;Wei Jiangbo(National Vaccine&Serum Institute,Beijing 101111,China)
出处 《中华实验和临床病毒学杂志》 CAS CSCD 2019年第6期637-640,共4页 Chinese Journal of Experimental and Clinical Virology
关键词 仙台病毒 实时荧光定量PCR 重组载体疫苗 Sendai virus Real-time fluorescence quantitative PCR Recombinant vector vaccine
  • 相关文献

参考文献2

二级参考文献16

  • 1Dani SU. The challenge of vector development in gene therapy. Braz J Med Biol Res, 1999, 32(2): 133-145.
  • 2Weber E, Anderson WF, Kasahara N. Recent advances in retrovirus vector-mediated gene therapy: teaching an old vector new tricks. Curr Opin Mol Ther, 2001, 3(5): 439-453.
  • 3Sandrin V, Russell SJ, Cosset FL. Targeting retroviral and lentiviral vectors. Curr Top Microbiol Immunol, 2003,281:137-178.
  • 4Stone D, David A, Bolognani F, et al. Viral vectors for gene delivery and gene therapy within the endocrine system. J Endocrinol, 2000, 164(2): 103-118.
  • 5Sakoda T, Kasahara N, Kedes L. Lentivirus vector-mediated gene transfer to cardiomyocytes. Methods Mol Biol, 2003, 219: 53-70.
  • 6Kafri T. Lentivirus vectors: difficulties and hopes before clinical trials. Curr Opin Mol Ther, 2001, 3(4): 316-326.
  • 7Ailles L, Schmidt M, Santoni-de-Sio FR, et al. Molecular evidence of lentiviral vector-mediated gene transfer into human self-renewing, multi-potent, long-term NOD/SCID repopulating hematopoietic cells. Mol Ther, 2002, 6(5): 615-626.
  • 8Barker E, Planelles V. Vectors derived from the human immunodeficiency virus, HIV-1. Front Biosci, 2003, 8: d491-d510.
  • 9Zhang WW. Development and application of adenoviral vectors for gene therapy of cancer. Cancer Gene Ther, 1999, 6(2): 113-138.
  • 10Hendriks WT, Ruitenberg MJ, Blits B, et al. Viral vector-mediated gene transfer of neurotrophins to promote regeneration of the injured spinal cord. Prog Brain Res, 2004, 146: 451-476.

共引文献22

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部